RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare neurological condition that can cause paralysis.
Several viruses are causing illnesses in Ohio and the U.S. See the symptoms for COVID-19, RSV, flu, norovirus and bird flu.
Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...
The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.
The Oneida County Health Department is warning residents about the growing number of cases of respiratory illnesses in the ...
For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...
RSV causes respiratory symptoms ranging from mild, cold-like discomfort to illnesses like bronchiolitis or pneumonia ...
The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...
The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback